SA
PACB icon

Sanctuary Advisors’s Pacific Biosciences PACB Stock Holding History

Sanctuary Advisors’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.9K Buy
37,458
+632
+2% +$919 ﹤0.01% 2759
2026
Q1 		$48.6K Buy
36,826
+1,946
+6% +$3.48K ﹤0.01% 2490
2025
Q4 		$65.2K Buy
34,880
+3,371
+11% +$6.48K ﹤0.01% 2366
2025
Q3 		$40.3K Buy
31,509
+673
+2% +$911 ﹤0.01% 2390
2025
Q2 		$38.2K Sell
30,836
-4,286
-12% -$4.95K ﹤0.01% 2322
2025
Q1 		$41.4K Sell
35,122
-335
-0.9% -$514 ﹤0.01% 2152
2024
Q4 		$56.7K Buy
35,457
+24,318
+218% +$47.5K ﹤0.01% 2348
2024
Q3 		$20.1K Buy
+11,139
New +$18.3K ﹤0.01% 2359

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Sanctuary Advisors's PACB Position: Q2 2026 in Review

Sanctuary Advisors increased its Pacific Biosciences (PACB) stake by 1.7% in Q2 2026, buying an estimated $919 and bringing the position to 37,458 shares worth $62.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2759.

Sanctuary Advisors first reported a position in PACB in Q3 2024 and has held it in 8 quarters since. The position peaked at $65.2K in Q4 2025. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Sanctuary Advisors held 37,458 shares of Pacific Biosciences worth $62.9K as of Q2 2026.
  • Sanctuary Advisors bought 632 Pacific Biosciences shares in Q2 2026, an estimated $919.
  • Pacific Biosciences made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #2759 holding.
  • Sanctuary Advisors first reported a position in Pacific Biosciences in Q3 2024 and has held it in 8 quarters since.
  • Sanctuary Advisors's Pacific Biosciences position peaked at $65.2K in Q4 2025.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.